*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>4-((4-methylpiperazin-1-yl)methyl)benzoic acid dihydrochloride</strong> is a key pharmaceutical intermediate synthesized via nucleophilic substitution of 4-(chloromethyl)benzoic acid with N-methylpiperazine, followed by hydrochloride salt formation. Molecular Formula: C<sub>12</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub>. CAS No.: 101836-59-5.</p>
<h3>Application</h3>
<ul>
<li>Medicinal Chemistry: Precursor for anti-inflammatory and analgesic drug synthesis.</li>
<li>API Manufacturing: Critical building block for developing novel heterocyclic compounds.</li>
<li>Research & Development: Used in high-throughput screening for receptor binding assays.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at 2-8°C to prevent degradation. Handle in fume hoods due to potential respiratory sensitization. Strictly regulated for human clinical trials; not for industrial or consumer use.</p>